Approval · Notice of Compliance 11767 · 2010

VIMPAT: Notice of Compliance 11767

Issued September 30, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 11767
Date: September 30, 2010
Company: Ucb Canada IncOakville, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: New Active Substance (NAS)
Therapeutic class: Antiepileptic agent

Products in this notice

Brand	DIN	Status today
VIMPAT	02357615	Marketed
VIMPAT	02357623	Marketed
VIMPAT	02357631	Marketed
VIMPAT	02357658	Marketed
VIMPAT	02357666	Marketed

Medicinal ingredients

LACOSAMIDE 50 MG per TAB
LACOSAMIDE 100 MG per TAB
LACOSAMIDE 150 MG per TAB
LACOSAMIDE 200 MG per TAB
LACOSAMIDE 10 MG per ML